Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,484 across all filing types
Latest filing 2023-09-11 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from Rositsa Doneva under Art. 19 of Regulation (EU) No 596/2014 of 8 September 2023.
Director's Dealing Classification · 100% confidence The document text contains structured tables detailing a 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It specifies the 'Position/status' of a person discharging managerial responsibilities (Rositsa Doneva), the 'Nature of the transaction' ('Buy'), and details of the transaction including price and volume for shares (ISIN № BG11SOSOBT18) executed on a specific date (8.9.2023) and place (BSE AD). This content directly corresponds to the reporting requirements for personal share transactions by company directors and executives, which is defined as Director's Dealing (DIRS).
2023-09-11 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 8 September 2023.
Director's Dealing Classification · 100% confidence The document explicitly states in the title: "Current report: 115/ 11.09.2023 NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". This directly corresponds to the reporting of personal share transactions by company directors and executives (insider trades), which is defined under the 'Director's Dealing' category (DIRS). The content details the person involved, their position, and the nature of the transaction (Sell).
2023-09-11 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 8 September 2023.
Director's Dealing Classification · 100% confidence The document text explicitly details a 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It lists details of a person discharging managerial responsibilities (or closely associated person) and their transaction ('Buy' of warrants). This content directly corresponds to the reporting requirements for insider trading or director's dealings, which maps to the 'Director's Dealing' category (DIRS). The structure and content are typical of MAR (Market Abuse Regulation) filings concerning insider transactions.
2023-09-11 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 8 September 2023.
Director's Dealing Classification · 100% confidence The document text clearly details a transaction involving a 'person discharging managerial responsibilities' (Ognian Donev) regarding the shares of an issuer ('Sopharma AD'). It specifies the nature of the transaction as 'Sell', the financial instrument (Shares, ISIN № BG11SOSOBT18), and provides aggregated price and volume data. This structure is characteristic of mandatory insider trading disclosures, specifically reporting personal share transactions by directors and executives. This aligns directly with the definition for Director's Dealing (DIRS).
2023-09-11 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 7 September 2023.
Director's Dealing Classification · 100% confidence The document is explicitly titled "Current report: 112/ 08.09.2023 NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". This content details transactions made by a person closely associated with a manager ('Vesela Stoeva is deputy chairperson of the Board of directors of "Sopharma" AD') regarding financial instruments. This directly corresponds to the definition of Director's Dealing (insider trades) as per the provided categories. The code for Director's Dealing is DIRS.
2023-09-08 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 7 September 2023.
Director's Dealing Classification · 100% confidence The document text details a notification concerning a transaction involving a 'person discharging managerial responsibilities/person closely associated' (Donev Investments Holding AD) related to an issuer (Sopharma AD). Specifically, it outlines the name, position, reason for notification, and details of the transaction involving a financial instrument (Warrants, ISIN № BG9200001212). This structure is characteristic of mandatory insider trading or director's dealing disclosures, often required under regulations like MAR (Market Abuse Regulation) in the EU. Among the provided codes, 'Director's Dealing (Code: DIRS)' is the most appropriate classification for reports detailing personal share transactions by company directors and executives (insider trades). The document is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific disclosure about insider transactions.
2023-09-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.